trending Market Intelligence /marketintelligence/en/news-insights/trending/yjsgy4svpddq2nvcwaxnbg2 content esgSubNav
In This List

Pfizer approves $10B share buyback, raises quarterly dividend by 6%

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Pfizer approves $10B share buyback, raises quarterly dividend by 6%

Pfizer Inc.'s board approved a new $10 billion share repurchase program.

This new program is in addition to the $4.9 billion remaining under the company's current buyback authorization.

The New York-based pharmaceutical company's board also approved a quarterly dividend of 36 cents per common share for the first quarter of 2019.

Pfizer said the dividend represents a 6% increase from the prior dividend of 34 cents per share and is payable March 1, 2019, to shareholders of record as of Feb. 1, 2019.